Meal replacement reduces insulin requirement, HbA1c and weight long‐term in type 2 diabetes patients with >100 U insulin per day

Abstract

Energy-restricted PRMR was effective in reducing insulin requirement of type 2 diabetes patients with intensified insulin therapy accompanied by a reduction of HbA1c, weight and other cardiometabolic risk factors. With the continuous use of PRMR, glycaemic control might be improved in the long term.